BACKGROUND: Improvements in treatment and management for pediatric central nervous system (CNS) tumors have increased survival rates, allowing clinicians to focus on long-term sequelae, including sleep disorders. The objective of this study was to describe a series of CNS tumor survivors who had sleep evaluations that included polysomnography (PSG) with attention to sleep disorder in relation to the tumor site. PROCEDURE: We report on 31 patients who had retrievable reports including an overnight PSG; 17 also underwent multiple sleep latency tests (MSLT) to characterize their sleepiness. RESULTS: Mean age at tumor diagnosis was 7.4 years, mean age at sleep referral 14.3 years, and a mean time between tumor diagnosis and sleep referral of 6.9 years. The most common tumor location was the suprasellar region, the most common reason for sleep referral was excessive daytime sleepiness (EDS), and the most common sleep diagnosis was obstructive sleep apnea (n = 14) followed by central sleep apnea (n = 4), hypersomnia due to medical condition (n = 4), and narcolepsy (n = 3). Twenty-six of the 31 subjects were obese/overweight, and among those with the concurrent complaint of EDS, the mean sleep latency on MSLT was 3.16 minutes, consistent with excessive sleepiness. CONCLUSIONS: Suprasellar region tumor survivors who are obese or overweight are more likely to have complaints of EDS and are at greater risk of sleep-disordered breathing. Sleep-related symptoms may not be recognized and referral initiated until years after CNS diagnosis. A periodic and thorough sleep history should be taken when caring for CNS tumor survivors.
BACKGROUND: Improvements in treatment and management for pediatric central nervous system (CNS) tumors have increased survival rates, allowing clinicians to focus on long-term sequelae, including sleep disorders. The objective of this study was to describe a series of CNS tumor survivors who had sleep evaluations that included polysomnography (PSG) with attention to sleep disorder in relation to the tumor site. PROCEDURE: We report on 31 patients who had retrievable reports including an overnight PSG; 17 also underwent multiple sleep latency tests (MSLT) to characterize their sleepiness. RESULTS: Mean age at tumor diagnosis was 7.4 years, mean age at sleep referral 14.3 years, and a mean time between tumor diagnosis and sleep referral of 6.9 years. The most common tumor location was the suprasellar region, the most common reason for sleep referral was excessive daytime sleepiness (EDS), and the most common sleep diagnosis was obstructive sleep apnea (n = 14) followed by central sleep apnea (n = 4), hypersomnia due to medical condition (n = 4), and narcolepsy (n = 3). Twenty-six of the 31 subjects were obese/overweight, and among those with the concurrent complaint of EDS, the mean sleep latency on MSLT was 3.16 minutes, consistent with excessive sleepiness. CONCLUSIONS: Suprasellar region tumor survivors who are obese or overweight are more likely to have complaints of EDS and are at greater risk of sleep-disordered breathing. Sleep-related symptoms may not be recognized and referral initiated until years after CNS diagnosis. A periodic and thorough sleep history should be taken when caring for CNS tumor survivors.
Authors: T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda Journal: Psychiatry Clin Neurosci Date: 2001-06 Impact factor: 5.188
Authors: Marina Tsaoussoglou; Edward O Bixler; Susan Calhoun; George P Chrousos; K Sauder; Alexandros N Vgontzas Journal: J Clin Endocrinol Metab Date: 2009-11-19 Impact factor: 5.958
Authors: Vikki G Nolan; Roxanna Gapstur; Cynthia R Gross; Lauren A Desain; Joseph P Neglia; Amar Gajjar; James L Klosky; Thomas E Merchant; Marilyn Stovall; Kirsten K Ness Journal: Qual Life Res Date: 2012-06-06 Impact factor: 4.147
Authors: Amanda M Rach; Valerie McLaughlin Crabtree; Tara M Brinkman; Lonnie Zeltzer; Jordan Gilleland Marchak; Deokumar Srivastava; Brooklee Tynes; Jin-Shei Lai; Leslie L Robison; Gregory T Armstrong; Kevin R Krull Journal: J Cancer Surviv Date: 2016-11-12 Impact factor: 4.442
Authors: Valerie McLaughlin Crabtree; Amanda M Rach; Kriston B Schellinger; Kathryn M Russell; Teresa Hammarback; Belinda N Mandrell Journal: Support Care Cancer Date: 2014-08-13 Impact factor: 3.603
Authors: Raja B Khan; Thomas E Merchant; Zsila S Sadighi; Mercedes S Bello; Zhaohua Lu; April Sykes; Merrill S Wise; Valerie M Crabtree; Jennifer Zabrowski; Andrea Simmons; Mary E Clark; Belinda N Mandrell Journal: J Neurooncol Date: 2017-11-08 Impact factor: 4.130
Authors: Lisa M Jacola; Heather M Conklin; Matthew A Scoggins; Jason M Ashford; Thomas E Merchant; Belinda N Mandrell; Robert J Ogg; Elizabeth Curtis; Merrill S Wise; Daniel J Indelicato; Valerie M Crabtree Journal: J Pediatr Psychol Date: 2016-05-16